Cargando…
Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes
OBJECTIVE: Several second-generation antipsychotic (SGA) drugs have been associated with weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid testing increased after the American Diabetes Association (ADA) consensus statement recommending metabolic monitoring for SGA-...
Autores principales: | Morrato, Elaine H., Newcomer, John W., Kamat, Siddhesh, Baser, Onur, Harnett, James, Cuffel, Brian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681020/ https://www.ncbi.nlm.nih.gov/pubmed/19244091 http://dx.doi.org/10.2337/dc08-1720 |
Ejemplares similares
-
Recent Advances in Understanding and Mitigating Adipogenic and Metabolic Effects of Antipsychotic Drugs
por: Gohlke, Julia M., et al.
Publicado: (2012) -
Consensus statement on diabetes in children
por: Prasanna Kumar, K. M., et al.
Publicado: (2014) -
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
por: Moghissi, Etie S., et al.
Publicado: (2009) -
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
por: Solomon, Sharon D., et al.
Publicado: (2017) -
Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation
por: Pignone, Michael, et al.
Publicado: (2010)